ATLAS 2026: Pharma CXO Roundtable
Navigate with Agentic AI Insights
Register nowEvent Overview
ATLAS 2026: Pharma CXO Roundtable invites senior pharma leaders to explore how Agentic AI is transforming the industry. Join this exclusive forum to navigate strategic frameworks, breakthrough use cases, and success stories that empower executives to drive innovation, optimize operations, and unlock high-impact business value with AI-driven insights.
Key Discussion Themes:
Agentic AI Implementation Framework
Discover the essential building blocks, governance models, and best practices required to implement Agentic AI confidently and at scale within pharma enterprises.
Transformative Agentic AI Use Cases for Pharma
Explore high-value, domain-specific Agentic AI applications that accelerate Research & Discovery, Clinical Development, Commercial, and operational outcomes—highlighting use cases that deliver measurable business impact.
Success Stories of Agentic AI Solutions with High-Impact Outcomes
Gain insights from real-world deployments showcasing how pharma organizations are leveraging Agentic AI to enhance decision-making, elevate customer experiences, and unlock new growth opportunities.
Agenda:
Fireside Chat Session
Blueprint to Pharma’s Agentic AI Future: Avoiding Pitfalls in Use Case Selection and Implementation
Roundtable Session
Operationalizing Agentic AI in Pharma: A practical dialogue on frameworks, innovation, and measurable business value
.webp)
Agilisium brings together distinguished Key Opinion Leaders who are shaping the future of Pharma with Agentic AI.
Their perspectives help decode emerging trends, validate real‑world use cases, and illuminate the strategic pathways that enterprises must adopt to drive meaningful business and scientific impact.
Industry Recognition
Agilisium Recognized as a Leader in Everest Group Life Sciences Digital Services for Mid-Market Enterprises PEAK Matrix® Report.
The Everest Group evaluated Agilisium’s capabilities across the Life Sciences value chain along with client case studies and references.
Agilisium Recognized as a Product Challenger in ISG Provider Lens™ Life Sciences and Healthcare Analytics Services — Specialist Providers 2024 study.
The ISG Group evaluated Agilisium’s expertise in enabling enterprises to improve decision-making utilizing AI and analytics.
Agilisium Recognized as a Product Challenger in ISG Provider Lens™ AWS Ecosystem Partners — Data Analytics, AI and ML Providers 2023 study.
The ISG Group evaluated Agilisium’s ability to utilize analytics and ML to convert data into insights, driving innovation and efficiency in client operations.
